Therefore, SKI-178 was invalid in SphK1/2-silenced cells, supporting that SphK inhibition should be the primary mechanism of SKI-178-induced cytotoxicity in prostate cancer cells. This evidence concerns the gene SPHK1 and Familial prostate cancer.